The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Interesting potential market - mobile high quality door to door testing?
https://www.dailymail.co.uk/news/article-10467937/Care-bosses-call-rapid-PCR-style-Covid-tests-brought-homes.html
@Lloyd
This presentation is not out of the ordinary, we had one same time last year, similarly for the November ones.
This presentation will be more interesting for it's future outlook on sales of existing products and any new products.
However, I'm pleased to see that a simple RNS notifying of a presentation has a surprisingly upbeat response from you, compared to your usual posts.
I'm sure the sales figures for the period quoted will be extremely light but I'm equally sure your predictive skills and inside knowledge of what is going to happen between now and the presentation will allow you to make a killing in trading this.
Good luck...
It seems GDR are scheduled for the publication of the advisory or so called 'medtech innovations' briefing held by NICE for one of our POC devices.
https://www.nice.org.uk/about/what-we-do/our-programmes/nice-advice/medtech-innovation-briefings
https://www.nice.org.uk/guidance/indevelopment?sp=on&nat=Medtech%20innovation%20briefings
Publication date is expected to be the 1st March.
My thoughts are this is likely for our AIHL POC. Hopefully one of the final hurdles to getting it into hospitals if it is :)
That sounds like a good question for the AGM on 30th Dec.
FYI
If anyone is interested, according to the AGM notice pdf on the Genedrive website, 'shareholders are encouraged to submit questions'. Questions can be submitted for the AGM by email to:
info@genedrive.com
with "AGM Question" in the subject line.
*make out to be
Apart from SNG in your examples, maybe Tiger16 makes all their money shorting stocks and ain't as 'confused' as they make to be !! Lol:)
GHIF have been with GDR for a while and are a more benevolent fund as opposed to a pure monetary one.
You must also remember that the number of shares in circulation has increased over 2.5 fold in the last 20mths, so their relative percentage would have shrunk anyway even after the recent raise uptake.
I see this RNS as purely an update and of neutral value.
# should read 'couldn't go the same way' doh!
Notaflipper wrote "Getting CE-IVD accreditation is one thing, selling is another, and the route to commercialisation is not cheap"
I'm not saying it could go the same way, but I believe GDR may have learned a lesson here and have now employed an in-house sales team which was missing before.
The AIHL launch should also be a success because they have at least one captive customer (NHS) and a very good sales partner in Inspiration Healthcare. But, then again I still have my fingers and toes crossed lol!
@HotChip
The Punit and £2 thing is a long term joke on this BB, not a serious post lol.
Good to see you're still optimistic there Punit ;)
Islandgirl said
"One of the quickest and most accurate POC PCR tests to be approved for EU use in 10 days."
POC not PCR, it is LAMP.
The Genedrive lab PCR test is one of the fastest & accurate available and is already commercially available but has not yet had any significant sales.
Davemcmanus wrote "Your post is just silly"
You're quite right Dave! Lol.
It was only meant to try and crack a teeny weeny smile on this poor BB's dour face.
I think this last year's performance of GDR has scarred a few of the longer term holders here so that any news whatsoever is met with "we're all dooomed!" lol.
How about we look at this particular piece of news with a different slant.
Here's my thinking.. how about we picture the following (imaginary) scenario ....
One of the reasons we performed badly is because the outgoing CFO wasn't strong enough to insist that other markets needed to be exploited and a stronger sales force required otherwise the company would be in financial shortfall. How about he wasn't authoritative enough to ask Mr B (and others) to justify salaries and bonuses without demonstrating significant sales, especially so soon after a prior 9mths of share dilution and a cash raise.
How about he didn't make the right choices as the company transformed from a research to a commercial footing in his 5yr tenure.
I'm not saying any of these are true. I'm just hypothesizing with my meandering mind.
Now how about we now say that the new CFO sweeps in and revolutionises the company's finances - make it more efficient and saves money in new ways. Galvanizes the sales force, is an all round a better captain of finance, puts fire into a staid board and maximises shareholder value. Whoosh!
The right appointment could make seriously make an enormous difference here, especially if correctly incentivised.
So maybe we're not "dooomed" after all....
Interesting programme long chat with CEO Warren East on this morning's Radio 5 "Wake Up To Money".
Mentions the full gamut of RR's products and developments including hybrid trains/planes micro grids and SMR.
https://www.bbc.co.uk/programmes/m00113dw
Should hopefully be available on catch up later - worth a listen.
I believe there may be a little confusion here.
PCR tests for AIHL may have been around for a while. The gene causing AIHL was identified back in 1993.
However, when a baby arrives into a unit and needs antibiotics immediately, there is not enough time to carry out the current test format and receive the result. Current strategies for monitoring this gene take upto 2wks within the NHS and the NHS alone has approx 90,000 such urgent admissions a year. So to quote a PALOH tweet "current tests are useless in this acute setting"
Hence why Genedrive (the company) were asked to develop an assay to use with their Genedrive (the device) to get an accurate result within the 'golden hour' for sepsis and which could be performed in-situ, without specialist staff and be non-invasive (cheek swab) - PALOH study.
But, I'm willing to listen if I've got the wrong end of the stick...
GarryGraham said:
"
Am I correct in assuming the government has guaranteed £150m towards Small Nucleur Reactors. This seems a drop in the ocean in comparison to other green energies such as wind turbines."
My understanding from an interview yesterday with the head of the consortium is that the £120m announced recently by the government is only for the next stage of the strategy which is 'enabling deployment' i.e. location/site assessments.
The next stage of project finance should be announced prior to COP26.
I believe the exchange rate will be fixed at the date of purchase (probably by TUI broker handling the RI). This would be similar to when dividends are quoted in € or $. I think the variety of £ being quoted is just shareholder's brokers making sure you have sufficient to cover e.g. my broker wrote this in their email -
"We don’t know the exact sterling cost yet. We’re asking you to make 190p available for each share you wish to buy."
Maybe those who partook in the previous RI can confirm. I find it hard to believe everyone could be charged differently.
IMHO
I did partake (partially) and had this email from my broker (HL) on 15th October @4pm (this last Friday) -
"The Open Offer has now been completed. All Elections have been satisfied in full.
.......
The resulting Shares have now been issued. As a result your 'account' has been updated"
So I believe the shares have been admitted. May be there'll be a confirmation RNS on Monday.
Have a look here.....
https://www.investopedia.com/investing/understanding-rights-issues/
HTH
* not yet received